[{"id": "5a2f11dae747473950714fb34a110815", "cik": "818033", "ticker": "HRTX", "name": "Kimberly Manhard", "position": "Executive Vice President, Drug Development", "year": 2021, "salary": 514937, "bonus": 0, "stockAwards": 583626, "optionAwards": 535147, "nonEquityIncentiveCompensation": 205975, "otherCompensation": 18893, "total": 1858578}, {"id": "bced6ec262bacc1fcb92b34d3c18ca10", "cik": "818033", "ticker": "HRTX", "name": "Barry Quart, Pharm.D.", "position": "Chief Executive Officer", "year": 2021, "salary": 700000, "bonus": 0, "stockAwards": 2061649, "optionAwards": 2268479, "nonEquityIncentiveCompensation": 392000, "otherCompensation": 8700, "total": 5430828}, {"id": "e15271c675c93a61df367a362c88eaf0", "cik": "818033", "ticker": "HRTX", "name": "John Poyhonen", "position": "President and Chief Commercial Officer", "year": 2021, "salary": 509748, "bonus": 0, "stockAwards": 583626, "optionAwards": 535147, "nonEquityIncentiveCompensation": 203899, "otherCompensation": 8700, "total": 1841120}, {"id": "8b6774c8808c40f78c60e84cc2539a8a", "cik": "818033", "ticker": "HRTX", "name": "Lisa Peraza", "position": "Vice President, Chief Accounting Officer", "year": 2021, "salary": 339900, "bonus": 0, "stockAwards": 247123, "optionAwards": 75530, "nonEquityIncentiveCompensation": 118965, "otherCompensation": 15237, "total": 796755}, {"id": "0669ac960d231bcd9cb41155f004a8a6", "cik": "818033", "ticker": "HRTX", "name": "David Szekeres", "position": "Executive Vice President, Chief Operating Officer", "year": 2021, "salary": 494400, "bonus": 0, "stockAwards": 583626, "optionAwards": 535147, "nonEquityIncentiveCompensation": 197760, "otherCompensation": 18498, "total": 1829431}, {"id": "b76474c251cdb4cd62ab76d21326167d", "cik": "818033", "ticker": "HRTX", "name": "Kimberly Manhard", "position": "Executive Vice President, Drug Development", "year": 2020, "salary": 519167, "bonus": 0, "stockAwards": 314400, "optionAwards": 1154364, "nonEquityIncentiveCompensation": 199976, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 8550, "total": 2196457}, {"id": "80072115acf2c8d7df923ef32959e0cc", "cik": "818033", "ticker": "HRTX", "name": "Robert Hoffman", "position": "Former Chief Financial Officer and Senior Vice President, Finance", "year": 2020, "salary": 360009, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 668287, "total": 1028296}, {"id": "65d585d2827318c496928a1456cc7bd3", "cik": "818033", "ticker": "HRTX", "name": "John Poyhonen", "position": "President and Chief Commercial Officer", "year": 2020, "salary": 513935, "bonus": 0, "stockAwards": 314400, "optionAwards": 1635349, "nonEquityIncentiveCompensation": 197960, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 8550, "total": 2670194}, {"id": "515bce20d672737cdf98c3c60d2310e7", "cik": "818033", "ticker": "HRTX", "name": "Barry Quart, Pharm.D.", "position": "Chief Executive Officer", "year": 2020, "salary": 676838, "bonus": 0, "stockAwards": 916995, "optionAwards": 3366895, "nonEquityIncentiveCompensation": 364991, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 21084, "total": 5346803}, {"id": "2473f937217c8b3ad71ee5483a8fbc4e", "cik": "818033", "ticker": "HRTX", "name": "David Szekeres", "position": "Executive Vice President, Chief Operating Officer", "year": 2020, "salary": 476910, "bonus": 0, "stockAwards": 314400, "optionAwards": 1500673, "nonEquityIncentiveCompensation": 161664, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 8550, "total": 2462197}, {"id": "0d9d5dbbee275f074cc6e176e8f43b70", "cik": "818033", "ticker": "HRTX", "name": "Lisa Peraza", "position": "Vice President, Chief Accounting Officer", "year": 2020, "salary": 328805, "bonus": 0, "stockAwards": 138855, "optionAwards": 990829, "nonEquityIncentiveCompensation": 105683, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 14567, "total": 1578739}, {"id": "089d32c5d1002bd548adf7ecce219a73", "cik": "818033", "ticker": "HRTX", "name": "Kimberly Manhard", "position": "Executive Vice President, Drug Development", "year": 2019, "salary": 490136, "bonus": 0, "stockAwards": 0, "optionAwards": 1815276, "nonEquityIncentiveCompensation": 196054, "otherCompensation": 8400, "total": 2509866}, {"id": "ccc52e74a4508fabe6a5b4652d3c5651", "cik": "818033", "ticker": "HRTX", "name": "Barry Quart, Pharm.D.", "position": "President and Chief Executive Officer", "year": 2019, "salary": 638991, "bonus": 0, "stockAwards": 0, "optionAwards": 4916373, "nonEquityIncentiveCompensation": 306715, "otherCompensation": 8400, "total": 5870479}, {"id": "7bef3c990fdebe00ba0354f71400ced9", "cik": "818033", "ticker": "HRTX", "name": "John Poyhonen", "position": "Executive Vice President, Chief Commercial Officer", "year": 2019, "salary": 216731, "bonus": 0, "stockAwards": 0, "optionAwards": 4211063, "nonEquityIncentiveCompensation": 90751, "otherCompensation": 6219, "total": 4524764}, {"id": "1945c6784631dc2cd7b8d7b346a22766", "cik": "818033", "ticker": "HRTX", "name": "Robert Hoffman", "position": "Chief Financial Officer and Senior Vice President, Finance", "year": 2019, "salary": 388714, "bonus": 0, "stockAwards": 0, "optionAwards": 1512730, "nonEquityIncentiveCompensation": 124388, "otherCompensation": 8400, "total": 2034232}, {"id": "56471d9df327d3e02cb88e4e5b7b2592", "cik": "818033", "ticker": "HRTX", "name": "Robert Rosen", "position": "Former President", "year": 2019, "salary": 78645, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 1022386, "total": 1101031}, {"id": "761d31acc9435b91e7ff515913ef9c2e", "cik": "818033", "ticker": "HRTX", "name": "Current Executive Officers", "position": "Barry Quart, Pharm.D. Current President and Chief Executive Officer", "year": 2018, "salary": 614414, "bonus": 0, "stockAwards": 0, "optionAwards": 4815660, "nonEquityIncentiveCompensation": 552973, "otherCompensation": 8250, "total": 5991297}, {"id": "8c8d03f7099104098c3b946cb7923916", "cik": "818033", "ticker": "HRTX", "name": "Kimberly Manhard", "position": "Executive Vice President Drug Development", "year": 2018, "salary": 466796, "bonus": 0, "stockAwards": 0, "optionAwards": 1605220, "nonEquityIncentiveCompensation": 350097, "otherCompensation": 8250, "total": 2430363}, {"id": "fa35f2c98f368105ae1fc7c93bfbf826", "cik": "818033", "ticker": "HRTX", "name": "Robert Rosen", "position": "Former President", "year": 2018, "salary": 614414, "bonus": 0, "stockAwards": 0, "optionAwards": 4815660, "nonEquityIncentiveCompensation": 552973, "otherCompensation": 0, "total": 5983047}, {"id": "3751106582c9e0326fe71f0cc907a87e", "cik": "818033", "ticker": "HRTX", "name": "John Poyhonen", "position": "Executive Vice President, Chief Commercial Officer", "year": 2018, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 0, "total": 0}, {"id": "eb40986b1f26cc95bd608b1667edd14f", "cik": "818033", "ticker": "HRTX", "name": "Robert Hoffman", "position": "Chief Financial Officer and Senior Vice President, Finance Former Executive Officer:", "year": 2018, "salary": 357438, "bonus": 0, "stockAwards": 0, "optionAwards": 1139706, "nonEquityIncentiveCompensation": 214463, "otherCompensation": 8027, "total": 1719634}, {"id": "94836dfdbd96d5a9217e48a01c56a118", "cik": "818033", "ticker": "HRTX", "name": "Barry Quart, Pharm.D.", "position": "President and Chief Executive Officer", "year": 2018, "salary": 614414, "bonus": 0, "stockAwards": 0, "optionAwards": 4815660, "nonEquityIncentiveCompensation": 552973, "otherCompensation": 8250, "total": 5991297}, {"id": "c70a0af1b84e4e651dd462b212323289", "cik": "818033", "ticker": "HRTX", "name": "Barry Quart, Pharm.D.", "position": "President and Chief Executive Officer", "year": 2017, "salary": 596518, "bonus": 0, "stockAwards": 0, "optionAwards": 3391524, "nonEquityIncentiveCompensation": 246958, "otherCompensation": 8100, "total": 4243100}, {"id": "a0ff8a8b3b2a09d0bc1a3d46a1c646b7", "cik": "818033", "ticker": "HRTX", "name": "John Poyhonen", "position": "Executive Vice President, Chief Commercial Officer", "year": 2017, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 0, "total": 0}, {"id": "3535fc25fb4e2525edcf8aba243507e3", "cik": "818033", "ticker": "HRTX", "name": "Kimberly Manhard", "position": "Executive Vice President Drug Development", "year": 2017, "salary": 453200, "bonus": 0, "stockAwards": 0, "optionAwards": 1312848, "nonEquityIncentiveCompensation": 156354, "otherCompensation": 8100, "total": 1930502}, {"id": "d10f6ee0d444215e0a0ce9980d6a26a8", "cik": "818033", "ticker": "HRTX", "name": "Robert Rosen", "position": "Former President", "year": 2017, "salary": 596518, "bonus": 0, "stockAwards": 0, "optionAwards": 3391524, "nonEquityIncentiveCompensation": 246958, "otherCompensation": 0, "total": 4235000}, {"id": "e790b08b9e376897f9408c9437253a71", "cik": "818033", "ticker": "HRTX", "name": "Robert H. Rosen", "position": "President", "year": 2017, "salary": 596518, "bonus": 0, "stockAwards": 0, "optionAwards": 3391524, "nonEquityIncentiveCompensation": 246958, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 0, "total": 4235000}, {"id": "88e2861724c99c4d0116fdfea9a8d207", "cik": "818033", "ticker": "HRTX", "name": "Brian G. Drazba", "position": "Vice President, Finance and Chief Financial Officer", "year": 2017, "salary": 91331, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 33923, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 441406, "total": 566660}, {"id": "422dd7dd44c577712a07f2ca12fc6146", "cik": "818033", "ticker": "HRTX", "name": "Robert Hoffman", "position": "Chief Financial Officer and Senior Vice President, Finance Former Executive Officer:", "year": 2017, "salary": 235577, "bonus": 0, "stockAwards": 0, "optionAwards": 1972207, "nonEquityIncentiveCompensation": 68425, "otherCompensation": 3635, "total": 2279844}, {"id": "b3f05786e7d2209981b83d0af23206f9", "cik": "818033", "ticker": "HRTX", "name": "Kimberly J. Manhard", "position": "Executive Vice President Drug Development", "year": 2017, "salary": 453200, "bonus": 0, "stockAwards": 0, "optionAwards": 1312848, "nonEquityIncentiveCompensation": 156354, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 8100, "total": 1930502}, {"id": "7780849a6f6f7737c1aacead76480ba5", "cik": "818033", "ticker": "HRTX", "name": "Current Executive Officers", "position": "Barry D. Quart, Pharm.D. Chief Executive Officer", "year": 2017, "salary": 596518, "bonus": 0, "stockAwards": 0, "optionAwards": 3391524, "nonEquityIncentiveCompensation": 246958, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 8100, "total": 4243100}, {"id": "e30117f3e26abd1255c7bbbb9a700dec", "cik": "818033", "ticker": "HRTX", "name": "Robert E. Hoffman", "position": "Chief Financial Officer and Senior Vice President, Finance Former Executive Officers:", "year": 2017, "salary": 235577, "bonus": 0, "stockAwards": 0, "optionAwards": 1972207, "nonEquityIncentiveCompensation": 68425, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 3635, "total": 2279844}, {"id": "b1d326cd32c99d689e49ad1a0828947e", "cik": "818033", "ticker": "HRTX", "name": "Robert H. Rosen", "position": "President", "year": 2016, "salary": 579143, "bonus": 0, "stockAwards": 0, "optionAwards": 2976744, "nonEquityIncentiveCompensation": 208492, "otherCompensation": 0, "total": 3764379}, {"id": "04d484592f2e0715927134cd3710bbe7", "cik": "818033", "ticker": "HRTX", "name": "Brian G. Drazba", "position": "Vice President, Finance and Chief Financial Officer", "year": 2016, "salary": 339230, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 108554, "otherCompensation": 7950, "total": 455734}, {"id": "a64c6004b13083cbce41ca2254077706", "cik": "818033", "ticker": "HRTX", "name": "Robert E. Hoffman", "position": "Chief Financial Officer and Senior Vice President, Finance Former Executive Officers:", "year": 2016, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 0, "total": 0}, {"id": "baaa45c09e6268b7f19a954387a514dd", "cik": "818033", "ticker": "HRTX", "name": "Kimberly J. Manhard", "position": "Executive Vice President, Drug Development Former Executive Officers:", "year": 2016, "salary": 401077, "bonus": 0, "stockAwards": 0, "optionAwards": 5801958, "nonEquityIncentiveCompensation": 132000, "otherCompensation": 7950, "total": 6342985}, {"id": "1023465dd46fc4e5cad849de6d1ad5bc", "cik": "818033", "ticker": "HRTX", "name": "Robert Rosen", "position": "Former President", "year": 2016, "salary": 579143, "bonus": 0, "stockAwards": 0, "optionAwards": 2976744, "nonEquityIncentiveCompensation": 208492, "otherCompensation": 0, "total": 3764379}, {"id": "070270a2aea1157466e14bb1dacb0438", "cik": "818033", "ticker": "HRTX", "name": "Robert Hoffman", "position": "Chief Financial Officer and Senior Vice President, Finance Former Executive Officer:", "year": 2016, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 0, "total": 0}, {"id": "437f717c6a2ca9e8dd9a3dbbfab52df6", "cik": "818033", "ticker": "HRTX", "name": "Paul G. Marshall", "position": "Senior Vice President, Technical Operations", "year": 2016, "salary": 319841, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 590060, "total": 909901}, {"id": "8096e6410975c87da37331c86c25d192", "cik": "818033", "ticker": "HRTX", "name": "Kimberly Manhard", "position": "Executive Vice President Drug Development", "year": 2016, "salary": 401077, "bonus": 0, "stockAwards": 0, "optionAwards": 5801958, "nonEquityIncentiveCompensation": 132000, "otherCompensation": 7950, "total": 6342985}, {"id": "b7ad786a7e5fa193db4ee931923e6b40", "cik": "818033", "ticker": "HRTX", "name": "Current Executive Officers", "position": "Barry D. Quart, Pharm.D. Chief Executive Officer", "year": 2016, "salary": 579143, "bonus": 0, "stockAwards": 0, "optionAwards": 2976744, "nonEquityIncentiveCompensation": 208492, "otherCompensation": 7950, "total": 3772329}, {"id": "ce47d36322361d45ffbd4ac58ecae3ab", "cik": "818033", "ticker": "HRTX", "name": "Current Executive Officers", "position": "Barry D. Quart, Pharm.D. Chief Executive Officer", "year": 2015, "salary": 551565, "bonus": 0, "stockAwards": 0, "optionAwards": 5582675, "nonEquityIncentiveCompensation": 333697, "otherCompensation": 7950, "total": 6475887}, {"id": "907102727638c88e4fd5016cf848bab7", "cik": "818033", "ticker": "HRTX", "name": "Neil J. Clendeninn, M.D., Ph.D.", "position": "Senior Vice President and Chief Medical Officer", "year": 2015, "salary": 84615, "bonus": 0, "stockAwards": 0, "optionAwards": 3239850, "nonEquityIncentiveCompensation": 0, "otherCompensation": 0, "total": 3324465}, {"id": "256af9f0b353c1a6a7210f9f67173e89", "cik": "818033", "ticker": "HRTX", "name": "Paul G. Marshall", "position": "Senior Vice President, Technical Operations", "year": 2015, "salary": 402900, "bonus": 0, "stockAwards": 0, "optionAwards": 1116535, "nonEquityIncentiveCompensation": 177276, "otherCompensation": 7950, "total": 1704661}, {"id": "cf947f3f5ab5a1754a6c4220be8b9d85", "cik": "818033", "ticker": "HRTX", "name": "Kimberly J. Manhard", "position": "Executive Vice President, Drug Development Former Executive Officers:", "year": 2015, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 0, "total": 0}, {"id": "8b870f1c28afa3b513951cecc1e4f53a", "cik": "818033", "ticker": "HRTX", "name": "Brian G. Drazba", "position": "Vice President, Finance and Chief Financial Officer", "year": 2015, "salary": 310650, "bonus": 0, "stockAwards": 0, "optionAwards": 1116535, "nonEquityIncentiveCompensation": 97855, "otherCompensation": 7950, "total": 1532990}, {"id": "4f79b0f10a5146e844abf4d38d10b24f", "cik": "818033", "ticker": "HRTX", "name": "Robert E. Hoffman", "position": "Chief Financial Officer and Senior Vice President, Finance Former Executive Officers:", "year": 2015, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 0, "total": 0}, {"id": "5a3b990020b1f1fcc68f2435664cf285", "cik": "818033", "ticker": "HRTX", "name": "Barry D. Quart, Pharm.D.", "position": "Chief Executive Officer", "year": 2015, "salary": 551565, "bonus": 0, "stockAwards": 0, "optionAwards": 5582675, "nonEquityIncentiveCompensation": 333697, "otherCompensation": 7950, "total": 6475887}, {"id": "a65ffcf698d0fe73013a93f5f2419bf2", "cik": "818033", "ticker": "HRTX", "name": "Robert H. Rosen", "position": "President and Chief Commercial Officer", "year": 2015, "salary": 551565, "bonus": 0, "stockAwards": 0, "optionAwards": 5582675, "nonEquityIncentiveCompensation": 333697, "otherCompensation": 0, "total": 6467937}, {"id": "3c236b2ef0c201c6bbc739e2a444b05b", "cik": "818033", "ticker": "HRTX", "name": "Kimberly J. Manhard", "position": "Executive Vice President, Drug Development Former Executive Officers:", "year": 2014, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 0, "total": 0}, {"id": "e65d805de6d5c4748d06e2226ddea6a8", "cik": "818033", "ticker": "HRTX", "name": "Robert H. Rosen", "position": "President and Chief Commercial Officer", "year": 2014, "salary": 540750, "bonus": 0, "stockAwards": 0, "optionAwards": 3325780, "nonEquityIncentiveCompensation": 252801, "otherCompensation": 0, "total": 4119331}, {"id": "5606fe895b93890c6cf6de41d542b334", "cik": "818033", "ticker": "HRTX", "name": "Neil J. Clendeninn, M.D., Ph.D.", "position": "Senior Vice President and Chief Medical Officer", "year": 2014, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 0, "total": 0}, {"id": "fba5b482abd1b9aa3660aa8cd104e526", "cik": "818033", "ticker": "HRTX", "name": "Brian G. Drazba", "position": "Vice President, Finance and Chief Financial Officer", "year": 2014, "salary": 285000, "bonus": 0, "stockAwards": 0, "optionAwards": 243502, "nonEquityIncentiveCompensation": 79088, "otherCompensation": 0, "total": 607590}, {"id": "6a976b77f839ac1cfcff6372d76f04ec", "cik": "818033", "ticker": "HRTX", "name": "Paul G. Marshall", "position": "Senior Vice President, Technical Operations Former Executive Officer:", "year": 2014, "salary": 395000, "bonus": 0, "stockAwards": 0, "optionAwards": 313074, "nonEquityIncentiveCompensation": 100725, "otherCompensation": 7800, "total": 816599}, {"id": "fd117323e5878d8820a09208e261c7de", "cik": "818033", "ticker": "HRTX", "name": "Mark S. Gelder, M.D.", "position": "Former Senior Vice President and Chief Medical Officer", "year": 2014, "salary": 412000, "bonus": 0, "stockAwards": 0, "optionAwards": 2124864, "nonEquityIncentiveCompensation": 105060, "otherCompensation": 7800, "total": 2649724}, {"id": "b85c86697608d97be59702330a67a600", "cik": "818033", "ticker": "HRTX", "name": "Barry D. Quart, Pharm.D.", "position": "Chief Executive Officer", "year": 2014, "salary": 540750, "bonus": 0, "stockAwards": 0, "optionAwards": 3082908, "nonEquityIncentiveCompensation": 252801, "otherCompensation": 7800, "total": 3884259}, {"id": "90f0ff45fec54c40669eb5c0b520a43a", "cik": "818033", "ticker": "HRTX", "name": "Current Executive Officers", "position": "Barry D. Quart, Pharm.D. Chief Executive Officer", "year": 2014, "salary": 540750, "bonus": 0, "stockAwards": 0, "optionAwards": 3082908, "nonEquityIncentiveCompensation": 252801, "otherCompensation": 7800, "total": 3884259}, {"id": "9c8bc50056e5a8d664020775f93a6ce0", "cik": "818033", "ticker": "HRTX", "name": "Barry D. Quart, Pharm.D.", "position": "Chief Executive Officer", "year": 2013, "salary": 349327, "bonus": 0, "stockAwards": 0, "optionAwards": 7625250, "nonEquityIncentiveCompensation": 240637, "otherCompensation": 41000, "total": 8256214}, {"id": "1789c44f8cf60c2e1e85fee06d2f2666", "cik": "818033", "ticker": "HRTX", "name": "Neil J. Clendeninn, M.D., Ph.D.", "position": "Senior Vice President and Chief Medical Officer", "year": 2013, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 0, "total": 0}, {"id": "b51a0250b6e36afa0ff952caacf9f4e3", "cik": "818033", "ticker": "HRTX", "name": "John B. Whelan", "position": "Former President and Chief Executive Officer; Former Chief Financial Officer", "year": 2013, "salary": 255615, "bonus": 0, "stockAwards": 0, "optionAwards": 1233750, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 522737, "total": 2012102}, {"id": "3a1932bca92ec77642b099880331c10c", "cik": "818033", "ticker": "HRTX", "name": "Brian G. Drazba", "position": "Vice President, Finance and Chief Financial Officer", "year": 2013, "salary": 52615, "bonus": 0, "stockAwards": 0, "optionAwards": 866800, "nonEquityIncentiveCompensation": 14250, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 0, "total": 933665}, {"id": "a7cd90012c78924f49ba90691cbe2b37", "cik": "818033", "ticker": "HRTX", "name": "Robert H. Rosen", "position": "President", "year": 2013, "salary": 453785, "bonus": 0, "stockAwards": 0, "optionAwards": 7872000, "nonEquityIncentiveCompensation": 317188, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 0, "total": 8642973}, {"id": "d75cd89c5544f34cc813fecaa8f0d83a", "cik": "818033", "ticker": "HRTX", "name": "Current Executive Officers", "position": "Barry D. Quart, Pharm.D. Chief Executive Officer", "year": 2013, "salary": 349327, "bonus": 0, "stockAwards": 0, "optionAwards": 7625250, "nonEquityIncentiveCompensation": 240637, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 41000, "total": 8256214}, {"id": "38a26b575c6271bb6dcb572e77a439f3", "cik": "818033", "ticker": "HRTX", "name": "Stephen R. Davis", "position": "Executive Vice President and Chief Operating Officer", "year": 2013, "salary": 266154, "bonus": 0, "stockAwards": 0, "optionAwards": 3727900, "nonEquityIncentiveCompensation": 133333, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 35000, "total": 4162387}, {"id": "c3f886d7dd8fafff1df5681cef5ea2ad", "cik": "818033", "ticker": "HRTX", "name": "Mark S. Gelder, M.D.", "position": "Senior Vice President and Chief Medical Officer Former Executive Officer", "year": 2013, "salary": 361539, "bonus": 0, "stockAwards": 0, "optionAwards": 730675, "nonEquityIncentiveCompensation": 162500, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 7650, "total": 1262364}, {"id": "cd12c84395f9defa4843fa2096db3202", "cik": "818033", "ticker": "HRTX", "name": "Paul G. Marshall", "position": "Senior Vice President, Technical Operations Former Executive Officer:", "year": 2013, "salary": 62288, "bonus": 0, "stockAwards": 0, "optionAwards": 2280180, "nonEquityIncentiveCompensation": 26333, "otherCompensation": 0, "total": 2368801}, {"id": "1570b4d2be1e40afe591676a7cc60665", "cik": "818033", "ticker": "HRTX", "name": "Brian G. Drazba", "position": "Vice President, Finance and Chief Financial Officer", "year": 2012, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 0, "total": 0}, {"id": "3ac8dde585361d9e371f8b319a642f68", "cik": "818033", "ticker": "HRTX", "name": "Current Executive Officers", "position": "Barry D. Quart, Pharm.D. Chief Executive Officer", "year": 2012, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 2461500, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 15000, "total": 2476500}, {"id": "0bdfc9ba909f3f79ca125df47bffc697", "cik": "818033", "ticker": "HRTX", "name": "Michael Adam, Ph.D.", "position": "Former Senior Vice President and Chief Operating Officer", "year": 2012, "salary": 312000, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 73700, "otherCompensation": 7500, "total": 393050}, {"id": "71113198776d3cb8129c24874d7cdf33", "cik": "818033", "ticker": "HRTX", "name": "Robert Rosen", "position": "Former Senior Vice President and Chief Commercial Officer; current President", "year": 2012, "salary": 65577, "bonus": 0, "stockAwards": 0, "optionAwards": 5733800, "nonEquityIncentiveCompensation": 15100, "otherCompensation": 5000, "total": 5819477}, {"id": "ad1dbef4bf8cee59192563005aa4ff06", "cik": "818033", "ticker": "HRTX", "name": "Stephen R. Davis", "position": "Executive Vice President and Chief Operating Officer", "year": 2012, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 2461500, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 15000, "total": 2476500}, {"id": "09c8f2bbc20b73037d560f4e0cb3a8ea", "cik": "818033", "ticker": "HRTX", "name": "John B. Whelan", "position": "Former President and Chief Executive Officer; current Chief Financial Officer", "year": 2012, "salary": 395000, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 128400, "otherCompensation": 7500, "total": 530750}, {"id": "ffa07a8b85465a5caad1c3ecdda371f1", "cik": "818033", "ticker": "HRTX", "name": "Mark S. Gelder, M.D.", "position": "Senior Vice President and Chief Medical Officer", "year": 2012, "salary": 26923, "bonus": 0, "stockAwards": 0, "optionAwards": 1697600, "nonEquityIncentiveCompensation": 0, "otherCompensation": 40000, "total": 1764523}, {"id": "6cd9c2bf52f0683f1b9dac3f07838b34", "cik": "818033", "ticker": "HRTX", "name": "Robert H. Rosen", "position": "President", "year": 2012, "salary": 65577, "bonus": 0, "stockAwards": 0, "optionAwards": 5733800, "nonEquityIncentiveCompensation": 15100, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 5000, "total": 5819477}, {"id": "14e1ac693ab990f762656daa414dfa67", "cik": "818033", "ticker": "HRTX", "name": "Paul G. Marshall", "position": "Senior Vice President, Technical Operations Former Executive Officer:", "year": 2012, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 0, "total": 0}, {"id": "d77e81ad686971dbe4a959597f8810e1", "cik": "818033", "ticker": "HRTX", "name": "Brian G. Drazba", "position": "Vice President, Finance and Chief Financial Officer", "year": 2011, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 0, "total": 0}, {"id": "491fc8881e516a9cb25e311e944fd3c0", "cik": "818033", "ticker": "HRTX", "name": "Robert H. Rosen", "position": "President", "year": 2011, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 0, "total": 0}, {"id": "8fc7b39f158180b8284f2539a04d2f00", "cik": "818033", "ticker": "HRTX", "name": "Michael Adam, Ph.D.", "position": "Sr. Vice President and Chief Operating Officer", "year": 2011, "salary": 216000, "bonus": 0, "stockAwards": 0, "optionAwards": 2443005, "nonEquityIncentiveCompensation": 109200, "otherCompensation": 5040, "total": 2773245}, {"id": "9b0e121f96f1194bd9feadac59a0894b", "cik": "818033", "ticker": "HRTX", "name": "Stephen R. Davis", "position": "Executive Vice President and Chief Operating Officer", "year": 2011, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 0, "total": 0}, {"id": "2f24bfebf99a10dbd62c7b36dda852c9", "cik": "818033", "ticker": "HRTX", "name": "Mark S. Gelder, M.D.", "position": "Senior Vice President and Chief Medical Officer", "year": 2011, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 0, "total": 0}, {"id": "67f8164f85687b00c561b1cb7240f9e3", "cik": "818033", "ticker": "HRTX", "name": "Current Executive Officers", "position": "Barry D. Quart, Pharm.D. Chief Executive Officer", "year": 2011, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 0, "total": 0}, {"id": "6d9871339b32259ef97cf8213b0cd70e", "cik": "818033", "ticker": "HRTX", "name": "Robert Rosen", "position": "Former Senior Vice President and Chief Commercial Officer; current President", "year": 2011, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 0, "total": 0}, {"id": "74283ef82be68129f138ae2ad58d533b", "cik": "818033", "ticker": "HRTX", "name": "John B. Whelan", "position": "President, Chief Executive Officer and Chief Financial Officer", "year": 2011, "salary": 354231, "bonus": 0, "stockAwards": 0, "optionAwards": 5357835, "nonEquityIncentiveCompensation": 197500, "otherCompensation": 7350, "total": 5916916}, {"id": "0462d0a69dd54bf45920f7eb7d63dbcd", "cik": "818033", "ticker": "HRTX", "name": "John Barr, Ph.D.", "position": "Sr. Vice President, Research and Development", "year": 2011, "salary": 290385, "bonus": 0, "stockAwards": 0, "optionAwards": 1467900, "nonEquityIncentiveCompensation": 63240, "otherCompensation": 8687, "total": 362491}, {"id": "ab80eb700c16ab7060473d497f0a4fde", "cik": "818033", "ticker": "HRTX", "name": "John B. Whelan", "position": "President, Chief Executive Officer and Chief Financial Officer", "year": 2010, "salary": 300000, "bonus": 0, "stockAwards": 0, "optionAwards": 363765, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 7350, "total": 671115}, {"id": "274a85d4ed17917af645fff260faf7d5", "cik": "818033", "ticker": "HRTX", "name": "Ronald J. Prentki", "position": "Former President and Chief Executive Officer", "year": 2010, "salary": 191250, "bonus": 0, "stockAwards": 0, "optionAwards": 462600, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 880422, "total": 1534272}, {"id": "cf5862a210e3aac21b61e07b4487a07e", "cik": "818033", "ticker": "HRTX", "name": "John Barr", "position": "Sr. Vice President, Research and Development", "year": 2010, "salary": 302000, "bonus": 0, "stockAwards": 0, "optionAwards": 363765, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 17082, "total": 682847}, {"id": "749c3bee0f94000d1887804de2984116", "cik": "818033", "ticker": "HRTX", "name": "Michael Adam, Ph.D.", "position": "Sr. Vice President and Chief Operating Officer", "year": 2010, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "otherCompensation": 0, "total": 0}, {"id": "073aca667765047fd3bc8beb51621a23", "cik": "818033", "ticker": "HRTX", "name": "John Barr, Ph.D.", "position": "Sr. Vice President, Research and Development", "year": 2010, "salary": 302000, "bonus": 0, "stockAwards": 0, "optionAwards": 363765, "nonEquityIncentiveCompensation": 0, "otherCompensation": 17082, "total": 682847}, {"id": "82062a9130475e90aff46029fa9e2f3a", "cik": "818033", "ticker": "HRTX", "name": "John Barr", "position": "Sr. Vice President, Research and Development", "year": 2009, "salary": 313616, "bonus": 0, "stockAwards": 0, "optionAwards": 112288, "nonEquityIncentiveCompensation": 47250, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 15450, "total": 488604}, {"id": "7188f1101f73535f2478d17290ed7995", "cik": "818033", "ticker": "HRTX", "name": "Ronald J. Prentki", "position": "President and Chief Executive Officer", "year": 2009, "salary": 441346, "bonus": 0, "stockAwards": 56786, "optionAwards": 0, "nonEquityIncentiveCompensation": 72000, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 7350, "total": 577482}, {"id": "65cdad5e28a7f3baf8bc2b85b62cea28", "cik": "818033", "ticker": "HRTX", "name": "John B. Whelan", "position": "Vice President, Chief Financial Officer", "year": 2009, "salary": 259616, "bonus": 0, "stockAwards": 0, "optionAwards": 211050, "nonEquityIncentiveCompensation": 40000, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 6923, "total": 517589}, {"id": "1c090c9e293408250f1d695e72bec7eb", "cik": "818033", "ticker": "HRTX", "name": "Anastassios Retzios", "position": "Former Vice President, Clinical Research", "year": 2008, "salary": 217081, "bonus": 0, "stockAwards": 0, "optionAwards": 48293, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 5665, "total": 271039}, {"id": "a98468d6c2bcf57d10e7399c8345889d", "cik": "818033", "ticker": "HRTX", "name": "Gregory Turnbull", "position": "Former President and Chief Executive Officer and Interim Chief Financial Officer", "year": 2008, "salary": 347154, "bonus": 0, "stockAwards": 12518, "optionAwards": 245279, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 31513, "total": 636464}, {"id": "44eeb0dbb6a93a4e556da792ff160ebb", "cik": "818033", "ticker": "HRTX", "name": "Ronald J. Prentki", "position": "President and Chief Executive Officer", "year": 2008, "salary": 196154, "bonus": 0, "stockAwards": 0, "optionAwards": 1646680, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 2942, "total": 1845776}, {"id": "c87320066c00b06b45eec1b8b8bc7bce", "cik": "818033", "ticker": "HRTX", "name": "Ronald Prentki", "position": "President and Chief Executive Officer", "year": 2008, "salary": 196154, "bonus": 0, "stockAwards": 0, "optionAwards": 199495, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 2942, "total": 398591}, {"id": "d7b5cf979298f2364fbee4e642c6f099", "cik": "818033", "ticker": "HRTX", "name": "John Barr", "position": "Sr. Vice President, Research and Development", "year": 2008, "salary": 290231, "bonus": 0, "stockAwards": 10631, "optionAwards": 87882, "nonEquityIncentiveCompensation": 30474, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 16223, "total": 435441}, {"id": "336405aff5b031dfd959691f3112374e", "cik": "818033", "ticker": "HRTX", "name": "John B. Whelan", "position": "Vice President, Chief Financial Officer", "year": 2008, "salary": 0, "bonus": 0, "stockAwards": 0, "optionAwards": 0, "nonEquityIncentiveCompensation": 0, "changeInPensionValueAndDeferredEarnings": 0, "otherCompensation": 0, "total": 0}, {"id": "aac7d01364ec91f8e465f7117bf79b49", "cik": "818033", "ticker": "HRTX", "name": "Gregory Turnbull", "position": "President and Chief Executive Officer", "year": 2007, "salary": 418000, "bonus": 0, "stockAwards": 9035, "optionAwards": 52285, "nonEquityIncentiveCompensation": 0, "otherCompensation": 31000, "total": 510320}, {"id": "22a5370a42274e97c535982266de85af", "cik": "818033", "ticker": "HRTX", "name": "John Barr", "position": "Sr. Vice President, Research and Development", "year": 2007, "salary": 262154, "bonus": 0, "stockAwards": 10602, "optionAwards": 32902, "nonEquityIncentiveCompensation": 55052, "otherCompensation": 17021, "total": 377731}, {"id": "c07b47ecee5712d6198edf9556bc19d8", "cik": "818033", "ticker": "HRTX", "name": "Michael O Connell", "position": "Former Chief Executive Officer, Chief Operating Officer and Chief Financial Officer", "year": 2007, "salary": 227585, "bonus": 0, "stockAwards": 21204, "optionAwards": 34794, "nonEquityIncentiveCompensation": 47793, "otherCompensation": 18447, "total": 349823}, {"id": "d05357842c0cc438a63e14bcbc6534ba", "cik": "818033", "ticker": "HRTX", "name": "Anastassios Retzios", "position": "Vice President, Clinical Research", "year": 2007, "salary": 208077, "bonus": 0, "stockAwards": 0, "optionAwards": 20562, "nonEquityIncentiveCompensation": 31212, "otherCompensation": 6242, "total": 266093}, {"id": "c3a91e38e11b6be5cf60a921677a9fe8", "cik": "818033", "ticker": "HRTX", "name": "Michael O Connell", "position": "Former Chief Executive Officer, Chief Operating Officer and Chief Financial Officer", "year": 2006, "salary": 345296, "bonus": 0, "stockAwards": 21111, "optionAwards": 53763, "nonEquityIncentiveCompensation": 24775, "otherCompensation": 17400, "total": 462345}, {"id": "a40904644102a6636f44f580a208bffe", "cik": "818033", "ticker": "HRTX", "name": "John Barr", "position": "Sr. Vice President, Research and Development", "year": 2006, "salary": 239608, "bonus": 0, "stockAwards": 10555, "optionAwards": 16602, "nonEquityIncentiveCompensation": 17192, "otherCompensation": 14400, "total": 298357}, {"id": "34dc3782900830f82a54d070f2664912", "cik": "818033", "ticker": "HRTX", "name": "Anastassios Retzios", "position": "Vice President, Clinical Research", "year": 2006, "salary": 19712, "bonus": 0, "stockAwards": 0, "optionAwards": 2310, "nonEquityIncentiveCompensation": 30000, "otherCompensation": 0, "total": 52022}, {"id": "da88790c026fb1db480ee4763bff0cf8", "cik": "818033", "ticker": "HRTX", "name": "Gregory Turnbull", "position": "President and Chief Executive Officer", "year": 2006, "salary": 38077, "bonus": 0, "stockAwards": 5072, "optionAwards": 48335, "nonEquityIncentiveCompensation": 0, "otherCompensation": 30584, "total": 122068}]